Trivarx Ltd has released a press release.
Appendix 4E - Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- June 2025 Quarterly Activities Report and Appendix 4C
- First patient recruited in innovative mental health trial
- March 2025 Quarterly Activities Report and Appendix 4C
- IRB approval for trial with US Dept of Veterans Affairs
- TrivarX Receives Firm Commitments to Raise $2.25 million
Later from TrivarX
- Trading Halt
- Positive interim results from US-veteran focused trial
- Pause in trade
- Inadvertent Lift of Trading Halt
- Suspension from Quotation
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX